KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Non-Current Deffered Revenue (2017 - 2019)

Historic Non-Current Deffered Revenue for Guardant Health (GH) over the last 3 years, with Q3 2019 value amounting to $10.6 million.

  • Guardant Health's Non-Current Deffered Revenue rose 3858.06% to $10.6 million in Q3 2019 from the same period last year, while for Sep 2019 it was $10.6 million, marking a year-over-year increase of 3858.06%. This contributed to the annual value of $7.8 million for FY2018, which is 1999.39% up from last year.
  • As of Q3 2019, Guardant Health's Non-Current Deffered Revenue stood at $10.6 million, which was up 3858.06% from $10.9 million recorded in Q2 2019.
  • Guardant Health's Non-Current Deffered Revenue's 5-year high stood at $10.9 million during Q2 2019, with a 5-year trough of $6.5 million in Q4 2017.
  • For the 3-year period, Guardant Health's Non-Current Deffered Revenue averaged around $8.7 million, with its median value being $8.4 million (2018).
  • As far as peak fluctuations go, Guardant Health's Non-Current Deffered Revenue surged by 1999.39% in 2018, and later surged by 3858.06% in 2019.
  • Over the past 3 years, Guardant Health's Non-Current Deffered Revenue (Quarter) stood at $6.5 million in 2017, then grew by 19.99% to $7.8 million in 2018, then surged by 34.68% to $10.6 million in 2019.
  • Its last three reported values are $10.6 million in Q3 2019, $10.9 million for Q2 2019, and $9.0 million during Q1 2019.